Simple Summary Cancer onset and progression are promoted by high deregulation of the
immune system. Recently, major advances in molecular and clinical cancer immunology …

Brain tumors are associated with adverse outcomes despite improvements in radiation
therapy, chemotherapy, and photodynamic therapy. However, treatment approaches are …

Background Copper ions are essential for cellular physiology. Cuproptosis is a novel
method of copper-dependent cell death, and the cuproptosis-based signature for glioma …

Background Glioblastoma multiforme (GBM) is extensively genetically and transcriptionally
heterogeneous, which poses challenges for classification and management. Long …

Objective: To establish a lncRNA panel related to ferroptosis, tumor progression, and
microenvironment for prognostic estimation in patients with glioma. Methods: LncRNAs …

The relationship between pyroptosis-related long non-coding RNAs (pyroptosis-related
lncRNAs) and glioma prognosis have not been studied clearly. Basing on The Cancer …

Malignant neoplasms are characterized by poor therapeutic efficacy, high recurrence rate,
and extensive metastasis, leading to short survival. Previous methods for grouping …

Glioblastoma is the most aggressive and lethal primary brain malignancy, with an average
patient survival from diagnosis of 14 months. Glioblastoma also usually progresses as a …

Glioma is the most common and aggressive tumor of the central nervous system. The
uncontrolled proliferation, cellular heterogeneity, and diffusive capacity of glioma cells …

Background: Glioma is the most common primary tumor of the central nervous system with a
high lethality rate. This study aims to mine fibroblast-related genes with prognostic value and …